In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Evista sales force recruitment by Management Recruitment, Inc. reprises Zyprexa strategy.

Executive Summary

LILLY EVISTA SALES FORCE RECRUITMENT BY MANAGEMENT RECRUITMENT, INC. will seek to duplicate the approach used by Lilly to bolster its sales force for the launch of Zyprexa. The company will hire new sales representatives in anticipation of a June submission of Evista (raloxifene) to FDA for treatment of postmenopausal women at risk for osteoporosis, and a 1998 submission for the treatment of established osteoporosis. MRI helped Lilly add 100 sales reps for the launch of the antipsychotic Zyprexa in October.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel